Biphasic insulin aspart‐30 reduces glycemic variability to a greater degree than insulin detemir: A randomized controlled trial of once‐daily insulin regimens using continuous glucose monitoring

INTRODUCTION: We compared the efficacy of insulin detemir and biphasic insulin aspart‐30 given in the morning as an add‐on to oral hypoglycemic agents in type 2 diabetes patients. MATERIALS AND METHODS: The present study enrolled 30 patients with poorly controlled type 2 diabetes (8% ≤ glycated hemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsujino, Daisuke, Nishimura, Rimei, Onda, Yoshiko, Seo, Chiaki, Ando, Kiyotaka, Utsunomiya, Kazunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934246/
https://www.ncbi.nlm.nih.gov/pubmed/28921908
http://dx.doi.org/10.1111/jdi.12747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934246/
https://www.ncbi.nlm.nih.gov/pubmed/28921908
http://dx.doi.org/10.1111/jdi.12747

Ejemplares similares